Trial Profile
Clevidipine versus nitroglycerin for blood pressure control in patients undergoing coronary artery bypass grafting
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 21 Apr 2014
Price :
$35
*
At a glance
- Drugs Clevidipine (Primary) ; Nitroglycerin
- Indications Perioperative hypertension
- Focus Therapeutic Use
- Sponsors The Medicines Company
- 21 Apr 2014 New trial record
- 04 Apr 2014 The primary end point "blood pressure response rate" has been met, according to article published in the Canadian Journal of Anesthesia.
- 04 Apr 2014 Results published in the Canadian Journal of Anesthesia.